Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CLVS - Clovis Oncology Inc


Previous close
0.0812
0   0%

Share volume: 0
Last Updated: Tue 20 Dec 2022 06:00:00 AM CET
Pharmaceutical Preparation Manufacturing : -2.88%

PREVIOUS CLOSE
CHG
CHG%

$0.08
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-03-31 2022-06-30 2022-09-30
Fiscal Quarter Q1 2022 Q2 2022 Q3 2022
Report Date 2022-05-05 2022-08-08 2022-11-09
Total revenue 34.247 M 32.143 M 30.663 M
Cost of revenue 8.070 M 7.872 M 7.265 M
Gross profit 26.177 M 24.271 M 23.398 M
    -7.28% -3.60%  
Operating expenses 71.463 M 69.016 M 61.167 M
Selling general and admin 29.213 M 32.590 M 30.380 M
Research and development 42.250 M 36.426 M 30.787 M
Total expenses 84.606 M 91.524 M 74.898 M
    8.18% -18.17%  
Operating income -50.359 M -59.381 M -44.235 M
Ebit -50.359 M -59.381 M -44.235 M
Pretax income -60.289 M -71.373 M -55.979 M
    18.38% -21.57%  
Income tax -120.000 K -41.000 K 35.000 K
Net income basic -60.169 M -71.332 M -56.014 M
    -18.55% 21.47%  
Net income -60.169 M -71.332 M -56.014 M
    -18.55% 21.47%